[1]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]STRONG VE,RUSSO A,YOON SS,et al.Comparison of young patients with gastric cancer in the United States and China[J].Ann Surg Oncol,2017,24(13):3964-3971.
[3]YIN J,SONG JN,BAI ZG,et al.Gastric cancer mortality trends in China (2006-2013) reveal increasing mortality in young subjects[J].Anticancer Res,2017,37(8):4671-4679.
[4]LIN JX,DESIDERIO J,LIN JP,et al.Multicenter validation study of the American Joint Commission on Cancer (8th Edition) for gastric cancer:proposal for a simplified and improved TNM staging system[J].J Cancer,2020,11(12):3483-3491.
[5]Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2014 (4th edition)[J].Gastric Cancer,2017,20(1):1-19.
[6]CLAVIEN PA,BARKUN J,DE OLIVEIRA ML,et al.The Clavien-Dindo classification of surgical complications:five-year experience[J].Ann Surg,2009,250(2):187-196.
[7]NOH SH,PARK SR,YANG HK,et al.Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLAISSIC):5-year follow-up of an open-label,randomized phase 3 trial[J].Lancet Oncol,2014,15(12):1389-1396.
[8]LIU W,QUAN H,CHEN X,et al.Clinicopathological features and prognosis of young gastric cancer patients following radical gastrectomy:a propensity score matching analysis[J].Sci Rep,2019,9(1):5943.
[9]梁奕志,房太勇.43例年轻胃癌患者的临床特点分析[J].福建医药杂志,2008,30(6):25-27.
LIANG YZ,FANG TY.Clinicopathological features of 43 cases of young gastric cancer patients[J].Fujian Med J,2008,30(6):25-27.
[10]SMITH BR,STABILE BE.Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young[J].Arch Surg,2009,144(6):506-510.
[11]KIM JH,BOO YJ,PARK JM,et al.Incidence and long-term outcome of young patients with gastric carcinoma according to sex:does hormonal status affect prognosis[J].Arch Surg,2008,143(11):1062-1067.
[12]RONA KA,SCHWAMEIS K,ZEHETNER J,et al.Gastric cancer in the young:an advanced disease with poor prognostic features[J].J Surg Oncol,2017,115(4):371-375.
[13]YANG Y,GAO P,SONG Y,et al.The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer:a meta-analysis[J].Eur J Surg Oncol,2016,42(8):1176-1182.
[14]XIAO H,ZHOU H,ZHANG P,et al.Association among the prognostic nutritional index,completion of adjuvant chemotherapy,and cancer-specific survival after curative resection of stage II/III gastric cancer[J].Eur J Clin Nutr,2020,74(4):555-564.
[15]TOKUNAGA M,TANIZAWA Y,BANDO E,et al.Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer[J].Ann Surg Oncol,2013,20(5):1575-1583.
[16]YU JI,LIM DH,LEE J,et al.Clinical outcomes and the role of adjuvant concurrent chemoradiation therapy in D2-resected LN-positive young patients (≤ 45 years) with gastric cancer[J].Anticancer Res,2019,39(10):5811-5820.